CoChat

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: Glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) agonism, used in the treatment of type 2 diabetes, has recently been shown to increase thermogenesis via the brain. As brown adipose tissue (BAT) produces heat by burning triacylglycerol (TG) and takes up glucose for de novo lipogenesis, the aim of this study was to evaluate the potential of chronic central GLP-1R activation by exendin-4 to facilitate clearance of lipids and glucose from the circulation by activating BAT. METHODS: Lean and diet-induced obese (DIO) C57Bl/6J mice were used to explore the effect of a 5 day intracerebroventricular infusion of the GLP-1 analogue exendin-4 or vehicle on lipid and glucose uptake by BAT in both insulin-sensitive and insulin-resistant conditions. RESULTS: Central administration of exendin-4 in lean mice increased sympathetic outflow towards BAT and white adipose tissue (WAT), resulting in increased thermogenesis as evidenced by increased uncoupling protein 1 (UCP-1) protein levels and decreased lipid content, while the uptake of TG-derived fatty acids was increased in both BAT and WAT. Interestingly, in DIO mice, the effects on WAT were blunted, while exendin-4 still increased sympathetic outflow towards BAT and increased the uptake of plasma TG-derived fatty acids and glucose by BAT. These effects were accompanied by increased fat oxidation, lower plasma TG and glucose concentrations, and reduced body weight. CONCLUSIONS/INTERPRETATION: Collectively, our results suggest that BAT activation may be a major contributor to the glucose- and TG-lowering effects of GLP-1R agonism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-015-3727-0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Central GLP-1R activation decreases body weight and food intake and induces activation of BAT in lean mice. Mice were treated for 5 days with i.c.v. exendin-4 (n = 8) or vehicle (control n = 9, pair-fed n = 6). On a daily basis, body weight (a, b) and food intake (c) were monitored. Samples of BAT and WAT were collected and stained for TH and UCP-1. Representative pictures and quantification of TH (d, e), UCP-1 (f, g) and lipid droplet content with H&E staining (h, i) are shown. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control; † p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed control
Fig. 1 Central GLP-1R activation decreases body weight and food intake and induces activation of BAT in lean mice. Mice were treated for 5 days with i.c.v. exendin-4 (n = 8) or vehicle (control n = 9, pair-fed n = 6). On a daily basis, body weight (a, b) and food intake (c) were monitored. Samples of BAT and WAT were collected and stained for TH and UCP-1. Representative pictures and quantification of TH (d, e), UCP-1 (f, g) and lipid droplet content with H&E staining (h, i) are shown. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control; † p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed controlCC BY · PubMed Central
Fig. 2 Central GLP-1R activation increases uptake of plasma TG-derived fatty acids and glucose by BAT in lean mice. Mice were treated for 5 days via i.c.v. (a–d) or i.v. (e–f) routes with exendin-4 (n = 8) or vehicle (control n = 9, pair-fed n = 6). After treatment, mice were injected with [3H]TO-labelled particles and [14C]DG. Plasma 3H activity (a) and 14C activity (c) were plotted relative to the injected dose. At 15 min after injection, organs were isolated and uptake of 3H activity (b, e) and 14C activity (d, f) was determined. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and †† p < 0.01 compared with pair-fed control. White bars/circles, control; black bars/circles, exendin-4; grey bars/circles, pair-fed control
Fig. 2 Central GLP-1R activation increases uptake of plasma TG-derived fatty acids and glucose by BAT in lean mice. Mice were treated for 5 days via i.c.v. (a–d) or i.v. (e–f) routes with exendin-4 (n = 8) or vehicle (control n = 9, pair-fed n = 6). After treatment, mice were injected with [3H]TO-labelled particles and [14C]DG. Plasma 3H activity (a) and 14C activity (c) were plotted relative to the injected dose. At 15 min after injection, organs were isolated and uptake of 3H activity (b, e) and 14C activity (d, f) was determined. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and †† p < 0.01 compared with pair-fed control. White bars/circles, control; black bars/circles, exendin-4; grey bars/circles, pair-fed controlCC BY · PubMed Central
Fig. 3 Central GLP-1R activation decreases body weight and shifts combustion from carbohydrates towards fat in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). Body weight gain (a) and food intake (b) were determined. Lean (crossed area) and fat (no cross) mass were measured (c). During the treatment period, mice were housed in metabolic cages. Fatty acid oxidation (d), carbohydrate oxidation (e), RER (f) and energy expenditure (g) were calculated from O2 uptake and CO2 excretion. (h) Magnitude of physical activity in arbitrary units. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and ††† p < 0.001 compared with pair-fed control. White bars/continuous lines, control; black bars/dotted lines, exendin-4; grey bars/dashed lines, pair-fed controls. AU, arbitrary units; CH, carbohydrate; EE, energy expenditure; FA, fatty acid
Fig. 3 Central GLP-1R activation decreases body weight and shifts combustion from carbohydrates towards fat in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). Body weight gain (a) and food intake (b) were determined. Lean (crossed area) and fat (no cross) mass were measured (c). During the treatment period, mice were housed in metabolic cages. Fatty acid oxidation (d), carbohydrate oxidation (e), RER (f) and energy expenditure (g) were calculated from O2 uptake and CO2 excretion. (h) Magnitude of physical activity in arbitrary units. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and ††† p < 0.001 compared with pair-fed control. White bars/continuous lines, control; black bars/dotted lines, exendin-4; grey bars/dashed lines, pair-fed controls. AU, arbitrary units; CH, carbohydrate; EE, energy expenditure; FA, fatty acidCC BY · PubMed Central
Fig. 4 Central GLP-1R activation increases TH and UCP-1 protein levels and decreases lipid droplet content in BAT in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). After treatment, mice were killed and BAT and WAT were collected and stained for TH and UCP-1. Staining with H&E was performed for lipid droplet content. Representative pictures and quantification of TH (a, b), UCP-1 (c, d) and lipid droplet content (e, f) are shown. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed control
Fig. 4 Central GLP-1R activation increases TH and UCP-1 protein levels and decreases lipid droplet content in BAT in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). After treatment, mice were killed and BAT and WAT were collected and stained for TH and UCP-1. Staining with H&E was performed for lipid droplet content. Representative pictures and quantification of TH (a, b), UCP-1 (c, d) and lipid droplet content (e, f) are shown. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed controlCC BY · PubMed Central
Fig. 5 Central GLP-1R activation increases uptake of plasma TG-derived fatty acids and glucose by BAT in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). After treatment, mice were injected with [3H]TO-labelled particles and [14C]DG. Plasma 3H activity (a) and 14C activity (c) were plotted relative to the injected dose. At 15 min after injection, organs were isolated and uptake of the 3H activity (b) and 14C activity (d) was determined. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and †† p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed control
Fig. 5 Central GLP-1R activation increases uptake of plasma TG-derived fatty acids and glucose by BAT in DIO mice. After 12 weeks of high-fat feeding, mice were treated for 5 days with i.c.v. exendin-4 (n = 10) or vehicle (control n = 6, pair-fed n = 9). After treatment, mice were injected with [3H]TO-labelled particles and [14C]DG. Plasma 3H activity (a) and 14C activity (c) were plotted relative to the injected dose. At 15 min after injection, organs were isolated and uptake of the 3H activity (b) and 14C activity (d) was determined. Values are mean ± SD. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with control. † p < 0.05 and †† p < 0.01 compared with pair-fed control. White bars, control; black bars, exendin-4; grey bars, pair-fed controlCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 140

Metadata

Authors
Kooijman, S., Wang, Y., Parlevliet, E. T., Boon, M. R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J. A., & Rensen, P. C. N.
Affiliations
  • Leiden University Medical Center (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Kooijman, Sander
Venue
Diabetologia
Published
2015-08-09
Volume
58
Issue
11
Pages
2637-2646
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2124135959
Cited by
140
References
32
Citations by year
2026: 5 · 2025: 11 · 2024: 17 · 2023: 17 · 2022: 14 · 2021: 9 · 2020: 12 · 2019: 12 · 2018: 19 · 2017: 14 · 2016: 8 · 2015: 2
FWCI
10.56
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (acceptedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
  • ZonMw
  • Leids Universitair Medisch Centrum
Topics
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
GLP-1 receptor, exendin-4, brown adipose tissue, thermogenesis, glucose uptake, diet-induced obesity, insulin resistance, sympathetic nervous system, UCP1, fat oxidation, white adipose tissue, type 2 diabetes
MeSH terms
Glucagon-Like Peptide-1 Receptor, Uncoupling Protein 1, Exenatide, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Body Composition, Adipose Tissue, Brown, Glucose, Insulin, Ion Channels, Male, Mice, Inbred C57BL, Peptides, Triglycerides, Venoms, Signal Transduction, Mitochondrial Proteins, Mice, Glucagon-Like Peptide 1, Incretins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice. https://app.cochat.ai/papers/10.1007/s00125-015-3727-0
The paper
Kooijman, S., Wang, Y., Parlevliet, E. T., Boon, M. R., Edelschaap, D., Snaterse, G., Pijl, H., Romijn, J. A., & Rensen, P. C. N. (2015). Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice. Diabetologia. https://doi.org/10.1007/s00125-015-3727-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.